scholarly journals Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA

2017 ◽  
Vol Volume 11 ◽  
pp. 75-82 ◽  
Author(s):  
Marco D DiBonaventura ◽  
William Wong ◽  
Bijal Shah-Manek ◽  
Mathias Schulz
Sign in / Sign up

Export Citation Format

Share Document